Rifampin

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • All forms of tuberculosis.
  • Treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx.

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Prosthetic valve endocarditis caused by staphylococci in combination with other agents (e.g. oxacillin/nafcillin, vancomycin) after blood cultures have cleared.
  • Prosthetic joint infections following debridement and retention of the prosthesis or 1-stage exchange.
  • Meningitis caused by penicillin and ceftriaxone resistant S. pneumoniae
  • Non-tuberculous mycobacterial infections (e.g. leprosy, MAC)
  • Brucellosis
  • Bartonella infections
  • Q-fever and rickettsialinfections
  • Cutaneous leishmaniasis
  • Legionella infections
  • Anthrax infections
  • NOTE: Rifampin is usually used in combination with other agents due to quick emergence of resistance if used as monotherapy.

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2023 Unbound Medicine, Inc. All rights reserved